1. Home
  2. ASRT

as of 12-05-2025 3:46pm EST

$0.76
$0.03
-3.19%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Chart Type:
Time Range:
Founded: 1995 Country:
United States
United States
Employees: N/A City: LAKE FOREST
Market Cap: 69.2M IPO Year: 1997
Target Price: $3.00 AVG Volume (30 days): 755.4K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.30 EPS Growth: N/A
52 Week Low/High: $0.51 - $1.04 Next Earning Date: 11-10-2025
Revenue: $137,354,000 Revenue Growth: 9.22%
Revenue Growth (this year): -9.89% Revenue Growth (next year): -0.20%

AI-Powered ASRT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 75.00%
75.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Assertio Holdings Inc. (ASRT)

Sell
ASRT Nov 10, 2025

Avg Cost/Share

$0.76

Shares

8,959

Total Value

$6,806.15

Owned After

98,541

SEC Form 4

Share on Social Networks: